Share
𝕏 Facebook LinkedIn

Cytotoxicity of carboplatin on human glioblastoma cells is reduced by exposure to ELF EMF (50 Hz, 70 G)

PAPER manual 2018 In vitro study Effect: mixed Evidence: Low

Abstract

Cytotoxicity of carboplatin on human glioblastoma cells is reduced by exposure to ELF EMF (50 Hz, 70 G) Amiri M, Basiri M, Eskandary H, Akbarnejad Z, Esmaeeli M, Masoumi-Ardakani Y, Ahmadi-Zeidabadi M. Cytotoxicity of carboplatin on human glioblastoma cells is reduced by the concomitant exposure to an extremely low-frequency electromagnetic field (50 Hz, 70 G). Electromagn Biol Med. 2018 May 30:1-8. doi: 10.1080/15368378.2018.1477052. Abstract Glioblastoma multiforme (GBM) is a malignant brain cancer that causes high mortality in patients. GBM responds weakly to the common cancer treatments such as chemotherapy and radiotherapy and even surgery. Carboplatin is an alkylating agent widely used to treat cancer. However, resistance to this drug is a common problem in its use in cancer treatment. Concomitant exposure to extremely low-frequency electromagnetic fields (ELF-EMFs) and carboplatin is one unexplored possibility for overcoming this resistance. Indeed, many lines of evidence show that EMF affects cancer cells and drug action. In this study, we evaluated the effect of concomitant administration of carboplatin and EMF (50 Hz, 70 G) and also concomitant administration of carboplatin and static magnetic field (SMF) (70 G) on human glioma cell line (U-87). The results showed that cotreatment reduced the efficiency of carboplatin in U-87 cells, by decreasing caspase-3 in comparison to drug groups. Overall, EMF reduced the apoptotic effect of carboplatin, possibly through a redox regulation mechanism. Therefore, we have to avoid coadministration of magnetic field (MF) and carboplatin in tumor area, because the MF decreased the toxicity of the drug. However, further studies are needed to reveal the action mechanism of this combination therapeutic method. ncbi.nlm.nih.gov

AI evidence extraction

At a glance
Study type
In vitro study
Effect direction
mixed
Population
Human glioma/glioblastoma cell line U-87
Sample size
—
Exposure
ELF laboratory exposure (ELF-EMF) and static magnetic field · 5.0E-5 MHz
Evidence strength
Low
Confidence: 74% · Peer-reviewed: yes

Main findings

In U-87 human glioma cells, concomitant exposure to an ELF-EMF (50 Hz, 70 G) with carboplatin reduced the efficiency/cytotoxic effect of carboplatin compared with drug-only groups, with decreased caspase-3. The authors conclude that EMF reduced the apoptotic effect of carboplatin; they also evaluated a static magnetic field (70 G) condition.

Outcomes measured

  • Carboplatin cytotoxicity/efficacy
  • Apoptosis
  • Caspase-3 (apoptosis marker)

Limitations

  • In vitro study (cell line model)
  • Exposure duration not reported in the abstract
  • Sample size and detailed methods not reported in the abstract
  • Mechanism described as possible; further studies needed

Suggested hubs

  • occupational-exposure (0.2)
    Study involves magnetic field exposure (ELF/SMF), though in a laboratory in vitro setting rather than a defined occupational cohort.
View raw extracted JSON
{
    "study_type": "in_vitro",
    "exposure": {
        "band": "ELF",
        "source": "laboratory exposure (ELF-EMF) and static magnetic field",
        "frequency_mhz": 5.00000000000000023960868011929647991564706899225711822509765625e-5,
        "sar_wkg": null,
        "duration": null
    },
    "population": "Human glioma/glioblastoma cell line U-87",
    "sample_size": null,
    "outcomes": [
        "Carboplatin cytotoxicity/efficacy",
        "Apoptosis",
        "Caspase-3 (apoptosis marker)"
    ],
    "main_findings": "In U-87 human glioma cells, concomitant exposure to an ELF-EMF (50 Hz, 70 G) with carboplatin reduced the efficiency/cytotoxic effect of carboplatin compared with drug-only groups, with decreased caspase-3. The authors conclude that EMF reduced the apoptotic effect of carboplatin; they also evaluated a static magnetic field (70 G) condition.",
    "effect_direction": "mixed",
    "limitations": [
        "In vitro study (cell line model)",
        "Exposure duration not reported in the abstract",
        "Sample size and detailed methods not reported in the abstract",
        "Mechanism described as possible; further studies needed"
    ],
    "evidence_strength": "low",
    "confidence": 0.7399999999999999911182158029987476766109466552734375,
    "peer_reviewed_likely": "yes",
    "keywords": [
        "extremely low-frequency electromagnetic field",
        "ELF-EMF",
        "50 Hz",
        "70 G",
        "static magnetic field",
        "SMF",
        "carboplatin",
        "glioblastoma",
        "U-87",
        "apoptosis",
        "caspase-3",
        "cytotoxicity"
    ],
    "suggested_hubs": [
        {
            "slug": "occupational-exposure",
            "weight": 0.200000000000000011102230246251565404236316680908203125,
            "reason": "Study involves magnetic field exposure (ELF/SMF), though in a laboratory in vitro setting rather than a defined occupational cohort."
        }
    ]
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.